Ceramedix, Inc.
Eliminating Organ Failure with Tissue Protection Therapies
6 employees · est. 2020 · New York, United States
TRexBio
Decoding Human Tissue Biology to Create Revolutionary Therapeutics
62 employees · est. 2018 · South San Francisco, United...
TRexBio is the older company (2020 vs 2018); TRexBio is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Ceramedix, Inc. | TRexBio |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2018 older |
| Headquarters | ||
| Headquarters | New York, United States | South San Francisco, United States |
| Employees | ||
| Employees | 6 | 62 larger |
| Industry | ||
| Industry | Biopharma, Health and Wellness, Pharmaceutical | Biopharma, Biotechnology, Clean Energy |
| Funding Stage | ||
| Funding Stage | Grant | Unknown |
| Total Funding | ||
| Total Funding | $3.01M | $219.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 6 |
| Services | ||
| Services | Not tracked yet | Development of biologics targeting immune balance, Decoding regulatory T cell behavior in human tissue, Creation of tissue-specific therapeutics |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with autoimmune diseases, Patients with inflammatory conditions, Healthcare providers in dermatology and gastroenterology |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Tissue Protection, Drug Development, Endothelial Tissue, Organ Failure Treatment, Scientific Research, Clinical Expertise, Medicinal Signaling Biology, New York City, Medical Innovation | Clinical-stage, Immunoregulatory Medicines, Tissue Biology, Computational Biology, Human Tissue Focus, Immunobiology Expertise, Treg Behavior Mapping, Novel Targets Identification, Therapeutic Intervention, TNFR2-selective Agonist, Effector Tregs Activation, Inflammatory Diseases, Atopic Dermatitis, Immune Homeostasis Restoration |
| Website | ||
| Website | ceramedix.com | trex.bio |
About Ceramedix, Inc.
Ceramedix, Inc. is a biopharmaceutical startup based in New York City focusing on developing breakthrough tissue protection and repair medicines. Founded in 2020, the company has garnered significant attention and funding from both private investors and government agencies, with its last investment...
About TRexBio
TRexBio is a clinical-stage biotechnology company that is focused on developing immunoregulatory medicines. Founded in 2018 and headquartered in South San Francisco, California, the company is pioneering advances in tissue Treg biology to combat inflammatory diseases. Their commitment to decoding hu...
We will tell you when either one moves
BounceWatch watches Ceramedix, Inc. and TRexBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ceramedix, Inc. and TRexBio — by email.
Frequently Asked Questions
Compare Ceramedix, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Ceramedix, Inc. on 12 Sep 2024, and TRexBio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.